CR8292A - Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion - Google Patents

Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion

Info

Publication number: CR8292A
Authority: CR; Costa Rica
Prior art keywords: dimetoxi; solvato; acetonic; docetaxel; preparation procedure
Prior art date: 2003-09-19

Application number

CR8292A

Other languages

English (en)

Inventor

Didier Eric

Perrin Marc-Antoine

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-19

Filing date

2006-03-15

Publication date

2008-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8292(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-15 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2008-10-15 Publication of CR8292A publication Critical patent/CR8292A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Oncology (AREA)
Hematology (AREA)
Epoxy Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cephalosporin Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CR8292A 2003-09-19 2006-03-15 Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion CR8292A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0311016A FR2859996B1 (fr)	2003-09-19	2003-09-19	Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (1)

Publication Number	Publication Date
CR8292A true CR8292A (es)	2008-10-15

Family

ID=34224354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR8292A CR8292A (es)	2003-09-19	2006-03-15	Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion

Country Status (38)

Country	Link
US (1)	US7241907B2 (es)
EP (1)	EP1667986B1 (es)
JP (1)	JP5010279B2 (es)
KR (1)	KR101123588B1 (es)
CN (1)	CN100429207C (es)
AR (1)	AR045667A1 (es)
AU (1)	AU2004274212B2 (es)
BE (1)	BE2013C036I2 (es)
BR (1)	BRPI0414492A8 (es)
CA (1)	CA2539309A1 (es)
CR (1)	CR8292A (es)
CY (2)	CY1114575T1 (es)
DK (1)	DK1667986T3 (es)
ES (1)	ES2403149T4 (es)
FR (2)	FR2859996B1 (es)
HK (1)	HK1093340A1 (es)
HR (1)	HRP20130322T1 (es)
HU (1)	HUS1300025I1 (es)
IL (1)	IL174240A (es)
LU (1)	LU92172I2 (es)
MA (1)	MA28045A1 (es)
ME (2)	MEP11708A (es)
MX (1)	MXPA06002639A (es)
MY (1)	MY136668A (es)
NO (2)	NO335997B1 (es)
NZ (1)	NZ545835A (es)
PA (1)	PA8612401A1 (es)
PE (1)	PE20050870A1 (es)
PL (1)	PL1667986T3 (es)
PT (1)	PT1667986E (es)
RS (2)	RS54614B1 (es)
RU (1)	RU2342373C2 (es)
SI (1)	SI1667986T1 (es)
TN (1)	TNSN06086A1 (es)
TW (1)	TWI382022B (es)
UA (1)	UA87115C2 (es)
WO (1)	WO2005028462A1 (es)
ZA (1)	ZA200602255B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007109654A2 (en) *	2006-03-21	2007-09-27	Dr. Reddy's Laboratories Ltd.	Docetaxel polymorphs and processes
US7855591B2 (en) *	2006-06-07	2010-12-21	Atmel Corporation	Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) *	2006-09-05	2010-01-26	Atmel Corporation	High efficiency low cost bi-directional charge pump circuit for very low voltage applications
US20080176958A1 (en)	2007-01-24	2008-07-24	Insert Therapeutics, Inc.	Cyclodextrin-based polymers for therapeutics delivery
FR2926551A1 (fr)	2008-01-17	2009-07-24	Aventis Pharma Sa	Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2013205442B2 (en) *	2008-01-17	2016-05-12	Aventis Pharma S.A.	Crystalline forms of dimethoxy docetaxel and methods for preparing same
WO2010019233A1 (en)	2008-08-11	2010-02-18	Nektar Therapeutics	Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr)	2009-05-06	2010-11-12	Sanofi Aventis	Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
CA2708489A1 (en) *	2009-10-29	2011-04-29	Aventis Pharma S.A.	Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
AU2015200149B2 (en) *	2009-10-29	2016-12-01	Aventis Pharma S.A.	Novel antitumoral use of cabazitaxel
ES2862340T3 (es) *	2009-10-29	2021-10-07	Sanofi Mature Ip	Nuevo uso antitumoral de cabazitaxel
US10894087B2 (en)	2010-12-22	2021-01-19	Nektar Therapeutics	Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en)	2010-12-22	2012-06-28	Nektar Therapeutics	Multi-arm polymeric prodrug conjugates of taxane-based compounds
EP2688877B1 (en)	2011-04-12	2017-03-08	Teva Pharmaceuticals International GmbH	Solid state forms of cabazitaxel and processes for preparation thereof
WO2013024495A1 (en) *	2011-08-18	2013-02-21	Dr. Reddys Laboratories Limited	Pharmaceutical formulations of cabazitaxel
TWI526437B (zh)	2011-09-09	2016-03-21	台灣神隆股份有限公司	卡巴他賽之結晶型
WO2013072766A2 (en)	2011-10-31	2013-05-23	Scinopharm Taiwan, Ltd.	Process for cabazitaxel and intermediates thereof
DE112012004569T5 (de)	2011-11-01	2014-08-14	Fresenius Kabi Oncology Ltd.	Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
CN104011035A (zh) *	2011-11-28	2014-08-27	费森尤斯卡比肿瘤学有限公司	卡巴他赛的晶型和用于制备其的方法
WO2013088335A1 (en)	2011-12-13	2013-06-20	Aventis Pharma S.A.	Crystalline form of cabazitaxel and process for preparing the same
US9403785B2 (en)	2012-01-03	2016-08-02	Shilpa Medicare Limited	Process for preparing amorphous cabazitaxel
EA201491506A1 (ru) *	2012-02-10	2014-12-30	Авентис Фарма С.А.	Новое применение кабазитаксела в педиатрии
WO2013134534A2 (en)	2012-03-08	2013-09-12	Plus Chemicals S.A.	Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) *	2012-05-10	2014-07-02	上海金和生物技术有限公司	一种卡巴他赛晶体及其制备方法
CN102746258B (zh)	2012-07-25	2015-02-04	重庆泰濠制药有限公司	卡巴他赛的结晶形式及其制备方法
WO2014022237A1 (en)	2012-07-31	2014-02-06	Yung Shin Pharm. Ind. Co., Ltd.	Amorphous cabazitaxel
WO2014028704A1 (en)	2012-08-15	2014-02-20	Yung Shin Pharm. Ind. Co., Ltd.	Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) *	2012-09-20	2016-04-20	齐鲁制药有限公司	7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
US20140094432A1 (en)	2012-10-02	2014-04-03	Cerulean Pharma Inc.	Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) *	2012-11-14	2014-05-21	上海希迈医药科技有限公司	一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) *	2012-12-12	2014-12-10	江苏奥赛康药业股份有限公司	卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en)	2012-12-13	2014-06-18	INDENA S.p.A.	New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910696B (zh) *	2012-12-30	2016-01-20	上海医药工业研究院	卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) *	2012-12-30	2016-01-20	上海医药工业研究院	卡巴他赛丙酮合物及其结晶
EP2777691A1 (en)	2013-03-14	2014-09-17	Pharmachemie B.V.	Taxoid - Purification of Liquid Excipients
EP2815749A1 (en)	2013-06-20	2014-12-24	IP Gesellschaft für Management mbH	Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
CN104277014A (zh) *	2013-07-04	2015-01-14	北京新天宇科技开发有限公司	二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
WO2015000165A1 (zh) *	2013-07-04	2015-01-08	北京新天宇科技开发有限公司	二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865674A1 (en)	2013-10-23	2015-04-29	INDENA S.p.A.	Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en)	2013-10-23	2015-04-29	INDENA S.p.A.	A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103601704B (zh) *	2013-11-22	2015-05-06	石家庄智恒医药科技有限公司	无定形卡巴他赛的制备
ES2904505T3 (es)	2015-01-12	2022-04-05	Emcure Pharmaceuticals Ltd	Formulación líquida de cabazitaxel
US10555926B2 (en) *	2015-02-17	2020-02-11	Erasmus University Medical Center Rotterdam	Use of cabazitaxel in the treatment of prostate cancer
EP3093014A1 (en)	2015-05-13	2016-11-16	Aventis Pharma S.A.	Cabazitaxel and its use for treating cancer
US10188626B2 (en)	2015-11-03	2019-01-29	Cipla Limited	Stabilized cabazitaxel formulations
IL266955B2 (en)	2016-11-29	2023-09-01	Ptc Therapeutics Mp Inc	Polymorphs of spiafatrin and its salts
MX2019006207A (es)	2016-11-29	2019-11-18	Censa Pharmaceuticals Inc	Forma polimorfica de sepiapterina.
EP3675863A4 (en)	2017-09-01	2021-01-27	PTC Therapeutics MP, Inc.	PHARMACEUTICAL COMPOSITION CONSISTING OF SEPIAPTERIN AND ITS USES
RS65874B1 (sr)	2018-05-30	2024-09-30	Ptc Therapeutics Mp Inc	Primena sepiapterina bez hrane za upotrebu u postupku za povećanje izloženosti plazme sepiapterinu
WO2020249507A1 (en)	2019-06-11	2020-12-17	Indena S.P.A.	Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en)	2019-10-15	2021-04-21	Sanofi Mature IP	Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en)	2019-09-25	2021-03-31	Sanofi Mature IP	Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5766635A (en) *	1991-06-28	1998-06-16	Rhone-Poulenc Rorer S.A.	Process for preparing nanoparticles
MA23823A1 (fr) *	1995-03-27	1996-10-01	Aventis Pharma Sa	Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) *	1996-03-06	1998-04-03	Rhone Poulenc Rorer Sa	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr)	1997-11-18	1999-12-17	Rhone Poulenc Rorer Sa	Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) *	1998-08-17	2002-02-12	Aventis Pharma S.A.	Use of a taxoid to treat abnormal cell proliferation in the brain
EP0982027A1 (en) *	1998-08-17	2000-03-01	Aventis Pharma S.A.	Taxoid derivatives for treating abnormal cell proliferation of the brain
US6136989A (en) *	1998-12-30	2000-10-24	Phytogen Life Sciences, Incorporated	Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) *	1999-01-07	1999-10-19	508037 (Nb) Inc.	Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
DK1178979T3 (da) *	1999-05-17	2004-03-22	Bristol Myers Squibb Co	Hidtil ukendte reaktionsbetingelser til spaltning af silylethere ved fremstillingen af paclitaxel (Taxol(R)) og paclitaxelanaloge
KR100886805B1 (ko) *	2001-11-29	2009-03-05	다이이찌 세이야꾸 가부시기가이샤	탁산 유도체 결정 및 그 제조방법

2003
- 2003-09-19 FR FR0311016A patent/FR2859996B1/fr not_active Expired - Lifetime
2004
- 2004-08-19 PE PE2004000799A patent/PE20050870A1/es not_active Application Discontinuation
- 2004-09-16 JP JP2006526663A patent/JP5010279B2/ja not_active Expired - Lifetime
- 2004-09-16 RS RS20060189A patent/RS54614B1/en unknown
- 2004-09-16 MX MXPA06002639A patent/MXPA06002639A/es active IP Right Grant
- 2004-09-16 DK DK04787385.6T patent/DK1667986T3/da active
- 2004-09-16 NZ NZ545835A patent/NZ545835A/en not_active IP Right Cessation
- 2004-09-16 AU AU2004274212A patent/AU2004274212B2/en active Active
- 2004-09-16 ES ES04787385T patent/ES2403149T4/es not_active Expired - Lifetime
- 2004-09-16 AR ARP040103329A patent/AR045667A1/es not_active Application Discontinuation
- 2004-09-16 RS YUP-2006/0189A patent/RS20060189A/sr unknown
- 2004-09-16 WO PCT/FR2004/002344 patent/WO2005028462A1/fr active Application Filing
- 2004-09-16 RU RU2006113122/04A patent/RU2342373C2/ru active Protection Beyond IP Right Term
- 2004-09-16 BR BRPI0414492A patent/BRPI0414492A8/pt not_active Application Discontinuation
- 2004-09-16 PA PA20048612401A patent/PA8612401A1/es unknown
- 2004-09-16 UA UAA200604360A patent/UA87115C2/ru unknown
- 2004-09-16 ME MEP-117/08A patent/MEP11708A/xx unknown
- 2004-09-16 ME MEP-2008-117A patent/ME00054B/me unknown
- 2004-09-16 SI SI200432016T patent/SI1667986T1/sl unknown
- 2004-09-16 CN CNB200480026128XA patent/CN100429207C/zh not_active Expired - Lifetime
- 2004-09-16 PT PT4787385T patent/PT1667986E/pt unknown
- 2004-09-16 KR KR1020067005396A patent/KR101123588B1/ko active IP Right Grant
- 2004-09-16 EP EP04787385A patent/EP1667986B1/fr not_active Expired - Lifetime
- 2004-09-16 PL PL04787385T patent/PL1667986T3/pl unknown
- 2004-09-16 CA CA002539309A patent/CA2539309A1/fr not_active Abandoned
- 2004-09-17 US US10/944,254 patent/US7241907B2/en active Active
- 2004-09-17 MY MYPI20043787A patent/MY136668A/en unknown
- 2004-09-17 TW TW093128097A patent/TWI382022B/zh active
2006
- 2006-03-09 IL IL174240A patent/IL174240A/en active IP Right Grant
- 2006-03-15 CR CR8292A patent/CR8292A/es unknown
- 2006-03-17 ZA ZA200602255A patent/ZA200602255B/en unknown
- 2006-03-17 TN TNP2006000086A patent/TNSN06086A1/en unknown
- 2006-03-17 MA MA28881A patent/MA28045A1/fr unknown
- 2006-04-19 NO NO20061714A patent/NO335997B1/no active Protection Beyond IP Right Term
- 2006-12-28 HK HK06114182.3A patent/HK1093340A1/xx not_active IP Right Cessation
2013
- 2013-03-20 LU LU92172C patent/LU92172I2/fr unknown
- 2013-04-10 HR HRP20130322TT patent/HRP20130322T1/hr unknown
- 2013-04-16 CY CY20131100313T patent/CY1114575T1/el unknown
- 2013-05-13 CY CY2013016C patent/CY2013016I2/el unknown
- 2013-06-07 HU HUS1300025C patent/HUS1300025I1/hu unknown
- 2013-06-13 BE BE2013C036C patent/BE2013C036I2/fr unknown
- 2013-07-04 FR FR13C0037C patent/FR13C0037I2/fr active Active
2015
- 2015-04-22 NO NO2015013C patent/NO2015013I1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
FR2859996A1 (fr)	2005-03-25
RS20060189A (en)	2008-06-05
PE20050870A1 (es)	2005-11-21
ES2403149T4 (es)	2013-06-24
FR13C0037I2 (fr)	2015-11-20
SI1667986T1 (sl)	2013-05-31
WO2005028462A1 (fr)	2005-03-31
EP1667986A1 (fr)	2006-06-14
TWI382022B (zh)	2013-01-11
NO2015013I1 (no)	2015-05-04
FR13C0037I1 (fr)	2013-09-08
AU2004274212B2 (en)	2010-03-04
US20050065138A1 (en)	2005-03-24
AU2004274212A1 (en)	2005-03-31
CN100429207C (zh)	2008-10-29
UA87115C2 (ru)	2009-06-25
HK1093340A1 (en)	2007-03-02
AR045667A1 (es)	2005-11-02
CY2013016I1 (el)	2018-01-10
KR20060072147A (ko)	2006-06-27
US7241907B2 (en)	2007-07-10
PT1667986E (pt)	2013-04-24
DK1667986T3 (da)	2013-05-06
MXPA06002639A (es)	2006-06-05
LU92172I2 (fr)	2013-05-21
ZA200602255B (en)	2007-07-25
TNSN06086A1 (en)	2007-10-03
NO20061714L (no)	2006-04-19
ES2403149T3 (es)	2013-05-14
HRP20130322T1 (en)	2013-07-31
NO2015013I2 (no)	2015-04-22
IL174240A (en)	2010-12-30
HUS1300025I1 (hu)	2016-08-29
CA2539309A1 (fr)	2005-03-31
RS54614B1 (en)	2016-08-31
JP5010279B2 (ja)	2012-08-29
ME00054B (me)	2011-02-10
PL1667986T3 (pl)	2013-06-28
RU2006113122A (ru)	2006-08-27
BRPI0414492A8 (pt)	2019-01-15
NO335997B1 (no)	2015-04-20
KR101123588B1 (ko)	2012-03-22
CY1114575T1 (el)	2016-10-05
FR2859996B1 (fr)	2006-02-03
NZ545835A (en)	2009-10-30
MEP11708A (en)	2010-06-10
LU92172I9 (es)	2019-01-03
MY136668A (en)	2008-11-28
CN1849311A (zh)	2006-10-18
TW200524891A (en)	2005-08-01
PA8612401A1 (es)	2005-08-04
MA28045A1 (fr)	2006-07-03
BRPI0414492A (pt)	2006-11-14
CY2013016I2 (el)	2018-01-10
JP2007505866A (ja)	2007-03-15
IL174240A0 (en)	2006-08-01
BE2013C036I2 (es)	2023-12-14
RU2342373C2 (ru)	2008-12-27
EP1667986B1 (fr)	2013-01-16

Publication	Publication Date	Title
CR8292A (es)	2008-10-15	Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion
ATE380007T1 (de)	2007-12-15	Dünne und trockene windel
MA28734B1 (fr)	2007-07-02	Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
DE602004025014D1 (de)	2010-02-25	Medizinische rückholvorrichtungen
NO20034465D0 (no)	2003-10-06	Medisinsk pasientsimulator
MA28575B1 (fr)	2007-05-02	Derives de la 1-amino-phthalazine, leur preparation , et leur application en therapeutique
MA28343A1 (fr)	2006-12-01	Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
MA29017B1 (fr)	2007-11-01	Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
MA28720B1 (fr)	2007-07-02	Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
DE60327474D1 (de)	2009-06-10	Medizinische schlinge
FR2866888B1 (fr)	2006-05-05	Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
FR2866885B1 (fr)	2007-08-31	Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
FR2891825B1 (fr)	2007-12-14	Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
DE602004016877D1 (de)	2008-11-13	Untersuchungsstuhl
MA28859B1 (fr)	2007-09-03	Hexadecasaccharides biotinyles, leur preparation et leur utilisation
FR2892416B1 (fr)	2008-06-27	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
DE502005007742D1 (de)	2009-09-03	Medizinische Zange
FR2893615B1 (fr)	2008-03-07	Derives de 3-acylindole, leur preparation et leur application en therapeutique
DE502004010917D1 (de)	2010-04-29	Rstellung und verwendung
NO20053898D0 (no)	2005-08-19	Use and proceeding at footballshoes
FR2874921B1 (fr)	2006-10-20	Derives de 3-spiro-indolin-2-one, leur preparation et leur application en therapeutique
FR2874215B1 (fr)	2006-09-29	Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique
FR2859108B1 (fr)	2008-01-11	Composition anti-stress et son inhalateur
ECSP066433A (es)	2006-11-16	Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion
DE502004009352D1 (de)	2009-05-28	Gerbstoffe und konservierungsmittel